Loading...

APC anti-mouse CD206 (MMR) Antibody

Pricing & Availability
Clone
C068C2 (See other available formats)
Regulatory Status
RUO
Other Names
MMR (macrophage mannose receptor), MR (mannose receptor), MRC1
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
C068C2_APC_1_082911
Thioglycollate-elicited BALB/c peritoneal macrophages were surface stained with CD107b (Mac-3) PE, and then intracellularly stained with CD206 (clone C068C2) APC (top) or rat IgG2a, κ APC isotype control (bottom).
  • C068C2_APC_1_082911
    Thioglycollate-elicited BALB/c peritoneal macrophages were surface stained with CD107b (Mac-3) PE, and then intracellularly stained with CD206 (clone C068C2) APC (top) or rat IgG2a, κ APC isotype control (bottom).
  • C068C2_APC_2_082911
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
141707 25 µg 131 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
141708 100 µg 296 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD206, also known as mannose receptor (MR), is a 175 kD type I membrane protein. It is a pattern recognition receptor (PRR) belonging to the C-type lectin superfamily. MR is expressed on macrophages, dendritic cells, Langerhans cells, and hepatic or lymphatic endothelial cells. MR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine through its C-type lectin-like carbohydrate recognition domains, sulfated carbohydrate antigens through its cysteine-rich domain, and collagens through its fibronectin type II domain. MR mediates endocytosis and phagocytosis as well as activation of macrophages and antigen presentation. It plays an important role in host defense and provides a link between innate and adaptive immunity. Recently, MR on lymphatic endothelial cells was found to be involved in leukocyte trafficking and a contributor to the metastatic behavior of cancer cells. It suggests that MR may be a potential target in controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Recombinant mouse CD206 (MMR)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
FC - Verified
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.

Application References

(PubMed link indicates BioLegend citation)
  1. Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed
  2. Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed
  3. Yang X, et al. 2015. PNAS. 112:2900. PubMed
  4. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  5. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Wang C, et al. 2018. J Pharmacol Exp Ther. 365:72. PubMed
  2. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  3. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  4. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  5. Liu C, et al. 2022. Regen Ther. 21:192. PubMed
  6. Liu J, et al. 2017. Mucosal Immunol. 10.1038/mi.2016.139. PubMed
  7. Poh AR, et al. 2017. Cancer Cell. 31:563. PubMed
  8. Liu C, et al. 2019. J Transl Med. 17:300. PubMed
  9. Zhang X, et al. 2017. J Cell Mol Med. 10.1111/jcmm.13329. PubMed
  10. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  11. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  12. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  13. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  14. Jeong J, et al. 2017. Sci Rep. 7:39848. PubMed
  15. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  16. Chang CF, et al. 2017. Neurobiol Dis. 103:54. PubMed
  17. Pilch Z, et al. 2018. Cancer Immunol Res. 6:930. PubMed
  18. Zhang J, et al. 2021. Front Cardiovasc Med. 8:737652. PubMed
  19. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  20. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  21. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  22. Giordano C, et al. 2014. Hum Mol Genet. . PubMed
  23. Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
  24. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  25. Tahiri H, et al. 2016. Sci Rep. 6:37391. PubMed
  26. Young JA, et al. 2020. Journal of Neuroendocrinology. e12854.. PubMed
  27. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  28. Nawaz A, et al. 2022. Nat Commun. 13:7058. PubMed
  29. Zhang L, et al. 2022. Acta Pharm Sin B. 12:3427. PubMed
  30. Chen X, et al. 2021. Cell Death Differ. 28:1237. PubMed
  31. Trott DW, et al. 2021. Geroscience. 43:1331. PubMed
  32. Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed
  33. Li S, et al. 2021. Ann Transl Med. 9:1644. PubMed
  34. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  35. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  36. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  37. Li Q, et al. 2021. Brain Behav Immun. 94:437. PubMed
  38. Wada N, et al. 2020. Mol Metab. 37:100988. PubMed
  39. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  40. Motoyama S, et al. 2020. Cells. :9. PubMed
  41. van Dierendonck XAMH, et al. 2020. Cell Reports. 30(6):1811-1822. PubMed
  42. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  43. Yan J, et al. 2018. Nat Commun. 9:33. PubMed
  44. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  45. Liao Y, et al. 2020. Mol Ther. 28:855. PubMed
  46. Hu M, et al. 2022. Can Respir J. 2022:5802938. PubMed
  47. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  48. Qiu J, et al. 2016. Sci Rep. 6:39407. PubMed
  49. Lasky C, et al. 2015. Infect Immun . 83: 2627 - 2635. PubMed
  50. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  51. Xie Z, et al. 2021. Open Life Sci. 16:653. PubMed
  52. Wu L, et al. 2022. Front Cell Dev Biol. 9:684842. PubMed
  53. Chen X, et al. 2022. J Appl Oral Sci. 30:e20220316. PubMed
  54. Calvo B, et al. 2020. IBRO Rep. 8:36. PubMed
  55. Jin RM, et al. 2017. J Immunol. 198:352. PubMed
  56. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  57. Zhang P, et al. 2022. BMC Med. 20:435. PubMed
  58. Xiao Y, et al. 2022. Clin Transl Med. 12:e1071. PubMed
  59. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  60. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  61. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  62. Taguchi K, et al. 2015. J Urol. . PubMed
  63. Ayala TS, et al. 2019. Sci Rep. 9:11447. PubMed
  64. Mallampalli RK, et al. 2021. Front Immunol. 12:735576. PubMed
  65. Taguchi K, et al. 2014. J Am Soc Nephrol. 25:1680. PubMed
  66. Rios-Doria J, et al. 2021. Front Oncol. 10:598477. PubMed
  67. Lee JY, et al. 2020. Nat Commun. 11:2358. PubMed
  68. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  69. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  70. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  71. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  72. Ganesan R, et al. 2020. FASEB J. 34:15888. PubMed
  73. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  74. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  75. Xue N, et al. 2017. Sci Rep. 7:39011. PubMed
  76. Rhys HI, et al. 2018. EBioMedicine. 29:60. PubMed
  77. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  78. Zhou X, et al. 2022. Front Pharmacol. 13:872188. PubMed
  79. Moya-Pérez A, et al. 2015. PLoS One. 10: 0126976. PubMed
  80. De Simone G, et al. 2021. Immunity. :. PubMed
  81. Luo J et al. 2018. Immunity. 49(1):107-119 . PubMed
  82. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  83. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  84. Zhang S, et al. 2021. J Inflamm Res. 14:4915. PubMed
  85. Sun M, et al. 2021. J Immunother Cancer. 9:. PubMed
  86. Fan Q, et al. 2021. Bioact Mater. 6:4014. PubMed
  87. Blriot C, et al. 2021. Immunity. :. PubMed
  88. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  89. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  90. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  91. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  92. Di Mitri D, et al. 2019. Cell Rep. 28:2156. PubMed
  93. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  94. Remmerie A, et al. 2020. Immunity. 53:641. PubMed
  95. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  96. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  97. Trott DW, et al. 2021. J Physiol. 599:3973. PubMed
  98. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  99. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  100. Zhang Y, et al. 2020. Mol Med Rep. 22:534. PubMed
  101. Kiyohara H, et al. 2018. Cell Mol Gastroenterol Hepatol. 7:135. PubMed
  102. Guo D, et al. 2022. Bone Res. 10:45. PubMed
  103. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  104. Li ZL, et al. 2021. Mol Ther Nucleic Acids. 25:502. PubMed
  105. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  106. Settelmeier S, et al. 2020. PLoS One. 15:e0233261. PubMed
  107. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
  108. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  109. He H, et al. 2012. Blood. 120:3152. PubMed
  110. Dai K, et al. 2015. J Leukoc Biol. 98: 1071 - 1080. PubMed
  111. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  112. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  113. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  114. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  115. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  116. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  117. Roux C, et al. 2021. Antioxidants (Basel). 10:. PubMed
  118. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  119. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  120. Lee SH, et al. 2018. J Exp Med. 215:357. PubMed
  121. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  122. Tang PC, et al. 2022. Adv Sci (Weinh). 9:e2101235. PubMed
  123. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  124. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  125. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  126. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  127. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  128. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  129. Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed
  130. Zhu Y, et al. 2021. Int J Oral Sci. 13:25. PubMed
  131. Filtjens J, et al. 2021. Nat Commun. 12:2936. PubMed
  132. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  133. Canan C, et al. 2014. J Leukoc Biol. 96:473. PubMed
  134. Baardman J et al. 2018. Cell reports. 25(8):2044-2052 . PubMed
  135. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  136. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  137. Kurelac I, et al. 2019. J Clin Med. 1.85. PubMed
  138. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  139. Song HY, et al. 2021. Mol Ther. S1525-0016:00472-X. PubMed
  140. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  141. Liu Y, et al. 2019. Am J Physiol Cell Physiol. 317:C762. PubMed
  142. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  143. Nasti A, et al. 2017. Eur J Immunol. 47:2163. PubMed
  144. Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed
  145. Ding T, et al. 2021. J Nanobiotechnology. 19:247. PubMed
  146. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
RRID
AB_10896057 (BioLegend Cat. No. 141707)
AB_10900231 (BioLegend Cat. No. 141708)

Antigen Details

Structure
Type I transmembrane protein, 175 kD, C-type lectin superfamily
Distribution

Macrophages, dendritic cells, Langerhans cells, liver endothelial cells

Function
Pathogen recognition, endocytosis and phagocytosis, antigen presentation
Ligand/Receptor
Antigen containing mannose, fucose, or an N-acetyl glucosamine
Cell Type
Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
Biology Area
Cell Biology, Immunology, Innate Immunity, Signal Transduction
Molecular Family
CD Molecules
Antigen References

1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501.
2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469.
3. Burgdorf S, et al. 2006. J. Immunol. 176:6770.
4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.

Gene ID
17533 View all products for this Gene ID
UniProt
View information about CD206 on UniProt.org

Related FAQs

Why is mouse CD206 stained intracellularly and not via surface staining?

Typically, mouse CD206 surface level is relatively low under normal conditions and so intracellular staining protocol is required to get better signal.

Go To Top Version: 3    Revision Date: 04.04.2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account